Hidden Bibliographic Details
| Other authors / contributors: | Zitvogel, L. (Laurence), editor.
Kroemer, Guido, editor.
|
|---|
| ISBN: | 9783319624310
3319624318
331962430X
9783319624303
9783319624303
|
|---|
| Digital file characteristics: | text file PDF
|
|---|
| Notes: | Includes bibliographical references.
Online resource; title from PDF title page (EBSCO, viewed December 27, 2017).
|
|---|
| Summary: | In this book, leading experts in cancer immunotherapy join forces to provide a comprehensive guide that sets out the main principles of oncoimmunology and examines the latest advances and their implications for clinical practice, focusing in particular on drugs with FDA/EMA approvals and breakthrough status. The aim is to deliver a landmark educational tool that will serve as the definitive reference for MD and PhD students while also meeting the needs of established researchers and healthcare professionals. Immunotherapy-based approaches are now inducing long-lasting clinical responses across multiple histological types of neoplasia, in previously difficult-to-treat metastatic cancers. The future challenges for oncologists are to understand and exploit the cellular and molecular components of complex immune networks, to optimize combinatorial regimens, to avoid immune-related side effects, and to plan immunomonitoring studies for biomarker discovery. The editors hope that this book will guide future and established health professionals toward the effective application of cancer immunology and immunotherapy and contribute significantly to further progress in the field.
|
|---|
| Other form: | Printed edition: 9783319624303
|
|---|
| Standard no.: | 10.1007/978-3-319-62431-0
|
|---|
